These results are supported by work recently published by Ojesina et al. [12], who observed HER2 amplification in a small percentage of cervical cancer patients and evidence of HER2 activation by somatic mutation, amplification, and human papilloma virus (HPV) integration in cervical cancer. The gene discussed is ERBB2; the disease is cervical cancer.